Application value of TCT combined with HR-HPV detection in early screening of cervical cancer and precancerous lesions
Objective To explore the practical value and effectiveness of liquid-based thin-layer cell test(TCT)combined with high-risk human papillomavirus(HR-HPV)detection in the early screening of cervical cancer and precancerous lesions.Meth-ods 2000 patients with cervical cancer and precancerous lesions were selected for early screening from January 2020 to January 2023.TCT and HR-HPV were performed.The diagnostic gold standard was based on the pathological results,and the consistency be-tween the single and combined detection of TCT and HR-HPV and the pathological results was compared.Results Pathological ex-amination showed among 2000 patients,396 cases were positive and 1604 cases were negative.For TCT+HR-HPV combined detec-tion method,its sensitivity was 94.41%,its specificity was 98.50%and its accuracy was 98.80%.All data were significantly higher than those of TCT single detection which was 80.00%,87.83%and 86.95%respectively,and those of HR-HPV single detection which was 82.10%,94.81%and 92.40%respectively,and the difference was statistically significant(P<0.05).The positive and negative predic-tive values of TCT+HR-HPV were 93.93%and 98.62%,which were significantly higher than those of TCT single detection which was 45.45%,97.19%and those of HR-HPV single detection which was 78.78%and 95.76%.The misdiagnosis rate and missed diagnosis rate were 5.58%and 1.51%which were significantly lower than those of TCT single detection being 20.00%and 12.17%,and those of HR-HPV single detection which was 17.89%and 5.18%,and the difference was statistically significant(P<0.05).Conclu-sion Early screening of cervical cancer and precancerous lesions by TCT+HR-HPV detection can significantly improve the accu-racy of diagnosis,contribute to early clinical diagnosis and treatment,improve the quality of diagnosis and treatment,and prolong the survival period of patients.